Global Generic Injectable Drugs Supply, Demand and Key Producers, 2026-2032
Description
The global Generic Injectable Drugs market size is expected to reach $ 43900 million by 2032, rising at a market growth of 3.4% CAGR during the forecast period (2026-2032).
Generic injectable drugs refer to sterile solutions (including emulsions and suspensions) made of drugs for injection into the body, and sterile powders or concentrated solutions that are prepared into solutions or suspensions before use.
The injection is fast and reliable, not affected by pH, enzymes, food, etc., has no first-pass effect, and can play a systemic or local positioning effect. It is suitable for patients who are not suitable for oral medicine and patients who cannot be taken orally. However, the development and production process of injections is complicated and safe. The body has poor adaptability and high cost.
In the segment of generic sterile injectable drugs, the Hospira (Pfizer Inc.) is the largest player, and Fresenius Kabi is the second. Top two players hold a share about 27% in 2019. The US market is dominated by two players like Hospira (Pfizer Inc.), Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent), Teva Pharmaceutical, Auromedics, Sanofi, Gland Pharma and Endo International PLC.
This report studies the global Generic Injectable Drugs demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Generic Injectable Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Generic Injectable Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Generic Injectable Drugs total market, 2021-2032, (USD Million)
Global Generic Injectable Drugs total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Generic Injectable Drugs total market, key domestic companies, and share, (USD Million)
Global Generic Injectable Drugs revenue by player, revenue and market share 2021-2026, (USD Million)
Global Generic Injectable Drugs total market by Type, CAGR, 2021-2032, (USD Million)
Global Generic Injectable Drugs total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Generic Injectable Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hospira (Pfizer Inc.), Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent), Teva Pharmaceutical, Auromedics, Sanofi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Generic Injectable Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Generic Injectable Drugs Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Generic Injectable Drugs Market, Segmentation by Type:
Small Molecule
Large Molecule
Global Generic Injectable Drugs Market, Segmentation by Application:
Oncology
Anesthesia
Anti-Infectives
Parenteral Nutrition
Cardiovascular Diseases
Companies Profiled:
Hospira (Pfizer Inc.)
Fresenius Kabi
Sandoz (Novartis)
Hikma Pharmaceuticals PLC
Dr. Reddy’s Laboratories Ltd
Grifols
Nichi-Iko Group (Sagent)
Teva Pharmaceutical
Auromedics
Sanofi
Gland Pharma
Endo International PLC
Key Questions Answered
1. How big is the global Generic Injectable Drugs market?
2. What is the demand of the global Generic Injectable Drugs market?
3. What is the year over year growth of the global Generic Injectable Drugs market?
4. What is the total value of the global Generic Injectable Drugs market?
5. Who are the Major Players in the global Generic Injectable Drugs market?
6. What are the growth factors driving the market demand?
Generic injectable drugs refer to sterile solutions (including emulsions and suspensions) made of drugs for injection into the body, and sterile powders or concentrated solutions that are prepared into solutions or suspensions before use.
The injection is fast and reliable, not affected by pH, enzymes, food, etc., has no first-pass effect, and can play a systemic or local positioning effect. It is suitable for patients who are not suitable for oral medicine and patients who cannot be taken orally. However, the development and production process of injections is complicated and safe. The body has poor adaptability and high cost.
In the segment of generic sterile injectable drugs, the Hospira (Pfizer Inc.) is the largest player, and Fresenius Kabi is the second. Top two players hold a share about 27% in 2019. The US market is dominated by two players like Hospira (Pfizer Inc.), Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent), Teva Pharmaceutical, Auromedics, Sanofi, Gland Pharma and Endo International PLC.
This report studies the global Generic Injectable Drugs demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Generic Injectable Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Generic Injectable Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Generic Injectable Drugs total market, 2021-2032, (USD Million)
Global Generic Injectable Drugs total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Generic Injectable Drugs total market, key domestic companies, and share, (USD Million)
Global Generic Injectable Drugs revenue by player, revenue and market share 2021-2026, (USD Million)
Global Generic Injectable Drugs total market by Type, CAGR, 2021-2032, (USD Million)
Global Generic Injectable Drugs total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Generic Injectable Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hospira (Pfizer Inc.), Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent), Teva Pharmaceutical, Auromedics, Sanofi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Generic Injectable Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Generic Injectable Drugs Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Generic Injectable Drugs Market, Segmentation by Type:
Small Molecule
Large Molecule
Global Generic Injectable Drugs Market, Segmentation by Application:
Oncology
Anesthesia
Anti-Infectives
Parenteral Nutrition
Cardiovascular Diseases
Companies Profiled:
Hospira (Pfizer Inc.)
Fresenius Kabi
Sandoz (Novartis)
Hikma Pharmaceuticals PLC
Dr. Reddy’s Laboratories Ltd
Grifols
Nichi-Iko Group (Sagent)
Teva Pharmaceutical
Auromedics
Sanofi
Gland Pharma
Endo International PLC
Key Questions Answered
1. How big is the global Generic Injectable Drugs market?
2. What is the demand of the global Generic Injectable Drugs market?
3. What is the year over year growth of the global Generic Injectable Drugs market?
4. What is the total value of the global Generic Injectable Drugs market?
5. Who are the Major Players in the global Generic Injectable Drugs market?
6. What are the growth factors driving the market demand?
Table of Contents
111 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World Generic Injectable Drugs Companies Competitive Analysis
- 4 United States VS China VS Rest of World (by Headquarter Location)
- 5 Market Analysis by Type
- 6 Market Analysis by Application
- 7 Company Profiles
- 8 Industry Chain Analysis
- 9 Research Findings and Conclusion
- 10 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
